Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) Poster presentations of post-hoc analyses from Study 403 including the prespecified patient population with MDD or bipolar depression with mixed features who also had anxious distress NEW YORK, […]
Category Archives: Pr Newswire
Pr Newswire
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement
23
Sep
Sep
European Microbiome Innovation for Health and Microbiome Therapeutics Innovation Group Announce New Collaboration Agreement Paris, France, September 23, 2024, 2:00 pm CET – The European Microbiome Innovation for Health (EMIH) association today announced an agreement between the Microbiome Therapeutics Innovation Group (MTIG) and EMIH for a collaboration to advance microbiome drug development, explore synergies between international regulators, and convene cross-continental […]
Pr Newswire
Elevar Therapeutics Resubmits New Drug Application to FDA for Combination of Camrelizumab plus Rivoceranib as First-Line Treatment Option for Unresectable Hepatocellular Carcinoma Boosted by CARES-310 Leading Overall Survival Analysis
23
Sep
Sep
FORT LEE, N.J., Sept. 23, 2024 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd., today announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational drug rivoceranib, an oral VEGF-TKI, in combination with camrelizumab, a PD-1 inhibitor, as a first-line […]
23
Sep
Sep
GARDEN CITY, N.Y., Sept. 23, 2024 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients, today that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will […]
Ikarao Launches Innovative Shell S1 Karaoke Machine: A New Era of Portable Entertainment LOS ANGELES, Sept. 23, 2024 /PRNewswire/ — Ikarao, a leading brand in the karaoke industry, has previously launched the popular Break X1 and Break X2 models. However, their high prices have left many consumers waiting for a more cost-effective product. Today, Ikarao is […]
Sercomm’s I-TEMP 10G PON SFP+ ONU is Now Certified with Harmonic’s cOS PON OLT Portfolio ATLANTA, Sept. 23, 2024 /PRNewswire/ — Sercomm Corporation (TWSE: 5388), a leading provider of telecom and broadband equipment, is pleased to announce the certification of its I-TEMP 10G SFP+ ONU for XGS-PON and 10G EPON with Harmonic’s cOS PON OLT […]
Strategic acquisition and further investment to accelerate AM Green’s vision to develop Chempolis’ technology into a global bio-refinery technology platform AM Green will invest ~ 1bn USD over next 3 years for production of 0.5 + MTPA of Sustainable Aviation Fuel (SAF) for global airline decarbonization AM Green will partner globally to create a bio-refinery […]
ASEAN Film Festival 2024 introduces over 20 free film screenings and 9 sharing sessions, receiving an enthusiastic response with over 3,500 tickets being redeemed HONG KONG, Sept. 23, 2024 /PRNewswire/ — The ASEAN Film Festival (AFF) 2024, organised by the Hong Kong ASEAN Foundation (HKAF), commenced earlier this month, introducing films from all 10 ASEAN countries to Hong Kong for the […]
HONG KONG, Sept. 23, 2024 /PRNewswire/ — The ‘final frontier’ has never been more accessible than it is now, with cutting-edge design and innovative technology ushering in a new era of space exploration, driven by the next generation of inventors from around the world. In the latest episode of ‘Tech for Good’, CNN anchor and […]
MELBOURNE, Australia, INDIANAPOLIS and LAKE MARY, Fla., Sept. 23, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and RLS (USA) Inc. (RLS, RLS Radiopharmacies), America’s only Joint Commission-accredited radiopharmacy network distributing PET[1], SPECT[2] and therapeutic radiopharmaceuticals, today announced an agreement by the Company to acquire RLS from its parent company, RLS Group […]